DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,511 filers reported holding DANAHER CORPORATION in Q4 2019. The put-call ratio across all filers is 1.66 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $324,636 | -74.9% | 1,300 | -76.8% | 0.00% | -66.7% |
Q4 2023 | $1,295,504 | -88.5% | 5,600 | -87.7% | 0.00% | -89.7% |
Q3 2023 | $11,263,740 | -93.5% | 45,400 | -93.7% | 0.03% | -93.4% |
Q2 2023 | $172,776,000 | -37.9% | 719,900 | -34.8% | 0.44% | -38.7% |
Q1 2023 | $278,378,180 | +511.6% | 1,104,500 | +544.0% | 0.72% | +465.4% |
Q4 2022 | $45,519,530 | +294.2% | 171,500 | +283.7% | 0.13% | +284.8% |
Q3 2022 | $11,546,000 | -16.0% | 44,700 | -17.5% | 0.03% | -15.4% |
Q2 2022 | $13,741,000 | +337.8% | 54,200 | +406.5% | 0.04% | +387.5% |
Q1 2022 | $3,139,000 | -97.4% | 10,700 | -97.1% | 0.01% | -97.4% |
Q4 2021 | $122,721,000 | -63.6% | 373,000 | -66.3% | 0.31% | -64.8% |
Q3 2021 | $336,954,000 | +400.2% | 1,106,800 | +269.8% | 0.87% | +371.9% |
Q1 2021 | $67,366,000 | -64.3% | 299,300 | -65.8% | 0.18% | -65.7% |
Q3 2020 | $188,636,000 | +216.5% | 876,031 | +159.9% | 0.54% | +208.0% |
Q2 2020 | $59,597,000 | -9.1% | 337,031 | -28.9% | 0.18% | -30.3% |
Q1 2020 | $65,569,000 | +2484.5% | 473,731 | +2765.7% | 0.25% | +4083.3% |
Q4 2019 | $2,537,000 | -24.0% | 16,531 | -28.4% | 0.01% | -25.0% |
Q3 2019 | $3,336,000 | -92.3% | 23,100 | -94.5% | 0.01% | -93.2% |
Q4 2018 | $43,345,000 | -66.3% | 420,333 | -64.5% | 0.12% | -62.4% |
Q3 2018 | $128,603,000 | +187.8% | 1,183,533 | +161.4% | 0.31% | +161.7% |
Q2 2018 | $44,686,000 | +97.1% | 452,833 | +95.6% | 0.12% | +96.7% |
Q1 2018 | $22,669,000 | -87.8% | 231,533 | -88.4% | 0.06% | -87.8% |
Q4 2017 | $185,428,000 | -22.7% | 1,997,720 | -28.6% | 0.50% | -26.5% |
Q3 2017 | $239,839,000 | +107.1% | 2,795,975 | +103.7% | 0.68% | +78.0% |
Q2 2017 | $115,814,000 | +1223.9% | 1,372,364 | +1121.2% | 0.38% | +1057.6% |
Q4 2016 | $8,748,000 | -83.9% | 112,381 | -83.8% | 0.03% | -85.7% |
Q3 2016 | $54,339,000 | +2752.4% | 693,184 | +3575.8% | 0.23% | +2210.0% |
Q2 2016 | $1,905,000 | +28.3% | 18,858 | +20.4% | 0.01% | +25.0% |
Q1 2016 | $1,485,000 | -75.7% | 15,658 | -78.2% | 0.01% | -79.5% |
Q3 2015 | $6,119,000 | -34.9% | 71,808 | -35.2% | 0.04% | -45.8% |
Q1 2015 | $9,403,000 | +526.4% | 110,757 | +460.6% | 0.07% | +500.0% |
Q3 2014 | $1,501,000 | -79.4% | 19,757 | -79.7% | 0.01% | -82.1% |
Q1 2014 | $7,303,000 | +281.4% | 97,357 | +292.6% | 0.07% | +272.2% |
Q4 2013 | $1,915,000 | -33.2% | 24,800 | -40.0% | 0.02% | -47.1% |
Q3 2013 | $2,867,000 | +311.3% | 41,357 | +276.0% | 0.03% | +240.0% |
Q2 2013 | $697,000 | – | 11,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |